An open-label phase 2 study of 2 doses of the hypoxia-inducible factor (HIF)-2a inhibitor belzutifan for the treatment of advanced clear cell renal cell carcinoma after progression on systemic therapy
Belzutifan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: An open-label phase 2 study of 2 doses of the hypoxia-inducible factor (HIF)-2a inhibitor belzutifan for the treatment of advanced clear cell renal cell carcinoma after progression on systemic therapy ### Output: Belzutifan